Search

Your search keyword '"M. CASTRO"' showing total 93 results

Search Constraints

Start Over You searched for: Author "M. CASTRO" Remove constraint Author: "M. CASTRO" Journal journal of allergy and clinical immunology Remove constraint Journal: journal of allergy and clinical immunology
93 results on '"M. CASTRO"'

Search Results

1. Relationship Between Clinical and Laboratory Criteria and Results of Double Blind Placebo Controlled Food challenge (DBPCFC) for the IgE Mediated Cow's Milk Allergy Diagnosis in Pediatric Patients

2. Evolutive Profile Of Iga Deficiency Patients From A Pediatric Brazilian Reference Center For Primary Immunodeficiency

Catalog

Books, media, physical & digital resources

3. X-linked Disorder Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-linked (ipex) In Brazilian Twins Brothers - A Report

4. Follow Up Of Hepatic Abscess In Chronic Granulomatous Disease (cgd): Clinical Experience Of A Brazilian Reference Center In Primary Imunodeficiecy (pid)

8. IgE Mediated Cow's Milk Allergy (CMA): Evaluation of Weight and Height of Patients at Admission and After one-year Follow-up in Use of Soy Products

9. Egg's allergy: an experience from Brazilian Food Allergy Reference Center

17. Transient hypogammaglobulinemia in a child with multiple infections and dysmorphic features*1

18. Wegener's granulomatosis in a 16-year-old girl*1

19. Latex allergy

21. 778 St. Louis asthma database

22. Mitochondrial DNA copy number variation in asthma risk, severity, and exacerbations.

23. Utility of eosinophil peroxidase as a biomarker of eosinophilic inflammation in asthma.

24. Eosinophils and tissue remodeling: Relevance to airway disease.

25. CCL5 is a potential bridge between type 1 and type 2 inflammation in asthma.

26. Bronchial epithelial cell transcriptional responses to inhaled corticosteroids dictate severe asthmatic outcomes.

27. The Precision Interventions for Severe and/or Exacerbation-Prone (PrecISE) Asthma Network: An overview of Network organization, procedures, and interventions.

28. Quantitative CT metrics are associated with longitudinal lung function decline and future asthma exacerbations: Results from SARP-3.

30. PrecISE: Precision Medicine in Severe Asthma: An adaptive platform trial with biomarker ascertainment.

31. Genetic analyses identify GSDMB associated with asthma severity, exacerbations, and antiviral pathways.

32. Distinct associations of sputum and oral microbiota with atopic, immunologic, and clinical features in mild asthma.

33. Baseline sputum eosinophil + neutrophil subgroups' clinical characteristics and longitudinal trajectories for NHLBI Severe Asthma Research Program (SARP 3) cohort.

34. Investigation of the relationship between IL-6 and type 2 biomarkers in patients with severe asthma.

35. Severe asthma during childhood and adolescence: A longitudinal study.

36. Development and initial validation of the Asthma Severity Scoring System (ASSESS).

37. Exacerbation-prone asthma in the context of race and ancestry in Asthma Clinical Research Network trials.

38. Reply.

39. Harmonized outcome measures for use in asthma patient registries and clinical practice.

40. Loss of bronchoprotection with ICS plus LABA treatment, β-receptor dynamics, and the effect of alendronate.

41. Racial disparities in asthma-related health care use in the National Heart, Lung, and Blood Institute's Severe Asthma Research Program.

42. Challenges in assessing the efficacy of systemic corticosteroids for severe wheezing episodes in preschool children.

43. Performance of the Asthma Impact on Quality of Life Scale (A-IQOLS) in diverse asthma research populations and demographic subgroups.

44. Refractory airway type 2 inflammation in a large subgroup of asthmatic patients treated with inhaled corticosteroids.

45. Lumen area change (Delta Lumen) between inspiratory and expiratory multidetector computed tomography as a measure of severe outcomes in asthmatic patients.

46. Recurrent wheezing in children following human metapneumovirus infection.

47. A new measure to assess asthma's effect on quality of life from the patient's perspective.

48. Obesity's effect on asthma extends to diagnostic criteria.

49. Income is an independent risk factor for worse asthma outcomes.

50. Quantitative computed tomographic imaging-based clustering differentiates asthmatic subgroups with distinctive clinical phenotypes.